"Be it cellulosic ethanol, renewable diesel, biomass-to-liquids (BTL) or Fischer Tropsch liquids, made from feedstocks such as agricultural or municipal solid wastes, grasses, woods, waste paper and algae, next-generation biofuels are still largely under Research & Development," said Tammy Klein, Executive Director of the Global Biofuels Center and the study leader.
Moreover, the study finds, mandates set that require next generation biofuels will not be met, particularly in the U.S. Currently, sugarcane ethanol from Brazil is the only commercially available, economical, low-carbon biofuel available on the market currently to meet U.S. RFS2 advanced biofuel and other low- carbon fuel requirements.
Other key findings include:
- Global ethanol demand will represent 12-14% of the global gasoline pool by 2015;
- Asia-Pacific ethanol production will grow tremendously in the coming years and could represent as much as 20% of global ethanol production by 2015;
- Of note, if India's own projections were realized, it could outpace Brazil in ethanol production and exporting by 2015. Nonetheless, despite India's ethanol production expansion Hart projects that Brazil will remain the leading global biofuels exporter.
Covering mainly ethanol and biodiesel, but also ETBE (ethyl tertiary butyl ether), cellulosic ethanol and renewable diesel (also known as non-ester biodiesel) where applicable, the Global Biofuels Outlook captures the current and near-term biofuels picture in 35 countries in the five key regions of the globe. The study reviews local and global drivers, public and fiscal policy developments, current and projected production capacity, and supply and demand projections for 2009, 2010 and 2015. This year, the study also includes a comprehensive matrix of next
Page: 1 2 3 4 Related biology technology :1
|SOURCE Hart Energy Publishing|
Copyright©2009 PR Newswire.
All rights reserved
. Global Experts Explore Entire Spectrum of Aids Vaccine Development2
. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference3
. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference4
. Touching 418 Billion Lives, Hepatitis Still Presents Significant Threat to Global Health5
. Touching 418 Million Lives, Hepatitis Still Presents Significant Threat to Global Health6
. Clinsys Clinical Research, Inc. Announces Key Hires, Rajagopalan Srinivasan, Ph.D, to Strengthen Global Biostatistics Service Offering and Christopher Gregory, Ph.D, to Scientific Affairs7
. Jazz Pharmaceuticals to Present at UBS Global Life Sciences Conference8
. A Large-Scale Research Project by a Dutch Consortium Addressing a Global Problem9
. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference10
. Allos Therapeutics to Present at the 2007 UBS Global Life Sciences Conference11
. Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference to Webcast Millennium Presentation